Adrenal function in hospitalised patients with pulmonary tuberculosis treated with rifampicin

dc.contributor.authorVenter, Willem Daniel Francois
dc.date.accessioned2009-02-13T08:49:51Z
dc.date.available2009-02-13T08:49:51Z
dc.date.issued2009-02-13T08:49:51Z
dc.description.abstractAbstract Introduction: Tuberculosis carries a high mortality in the days immediately after treatment. It is also the commonest cause of adrenal insufficiency in the developing world. Rifampicin is a potent hepatic enzyme inducer, and may contribute to adrenal insufficiency by accelerating cortisol breakdown. The aim of the study was to determine whether rifampicin induced accelerated catabolism of corticosteroids. Methods: A prospective, randomised study comparing adrenal function in 20 patients with pulmonary tuberculosis in the first five days treated with two different antituberculosis regimens, one containing rifampicin, and the other ciprofloxacin. Results: Demographic, clinical and laboratory results were similar in both groups. Both groups showed a statistically significant and similar decrease in morning cortisol, with similar responses to ACTH stimulation at both 30 and 60 minutes before and after four days of treatment. In the entire cohort, 40% demonstrated an incremental cortisol rise of <250nmol/l after ACTH stimulation on day 1. Mean basal cortisol concentrations were substantially elevated and DHEA-S levels were consistently subnormal, resulting in a high cortisol:DHEA-S ratio. No patient demonstrated overt adrenal insufficiency. There were no significant differences between the two groups before or during therapy for any electrolytes, hormones or calculated serum osmolality. Conclusions: Rifampicin did not additionally impair adrenocortical function during the initial period of therapy.en
dc.identifier.urihttp://hdl.handle.net/10539/6109
dc.language.isoenen
dc.subjecttuberculosisen
dc.subjectTBen
dc.subjectrifampicinen
dc.subjectadrenal functionen
dc.subjecthospital patientsen
dc.titleAdrenal function in hospitalised patients with pulmonary tuberculosis treated with rifampicinen
dc.typeThesisen
Files
Original bundle
Now showing 1 - 5 of 6
No Thumbnail Available
Name:
MastersVENTERpart1.pdf
Size:
12.59 KB
Format:
Adobe Portable Document Format
No Thumbnail Available
Name:
MastersVENTERpart2.pdf
Size:
234.03 KB
Format:
Adobe Portable Document Format
Description:
No Thumbnail Available
Name:
references.pdf
Size:
18.6 KB
Format:
Adobe Portable Document Format
Description:
No Thumbnail Available
Name:
appendix 1.pdf
Size:
349.11 KB
Format:
Adobe Portable Document Format
Description:
No Thumbnail Available
Name:
appendix2compressed.pdf
Size:
478.06 KB
Format:
Adobe Portable Document Format
Description:
License bundle
Now showing 1 - 1 of 1
No Thumbnail Available
Name:
license.txt
Size:
92 B
Format:
Item-specific license agreed upon to submission
Description:
Collections